Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2007
02/22/2007US20070042977 Vaccine
02/22/2007US20070042965 Crystallized structure of type IV collagen NC1 domain hexamer
02/22/2007US20070042963 Therapeutic peptides
02/22/2007US20070042960 Use of Zven human proteins as agents that stimulate gastrointestinal contractility, gastric emptying, intestinal transit, and treating gastroparesis
02/22/2007US20070042959 Thrombin-inhibiting peptides
02/22/2007US20070042958 Immunoglobulins; myostatins; for treatment of neuronal diseases, muscle and bone conditions, and metabolic disorders; improved solubility, pharmacokinetics
02/22/2007US20070042956 Novel GLP-1 compounds
02/22/2007US20070042954 Soluble G-protein coupled receptors (sGPCR); corticotropin releasing factor receptor type 2 (sCRFR2) attached to affinity tag, fluorescent label, immunoglobulin domain or conjugated to polyoxyethylene glycol; skin, gastrointestinal, bipolar, and psychological disorders; drug abuse; anxiolytic agents
02/22/2007US20070042952 Analogues of glp-1
02/22/2007US20070042950 Antagonistic analogs of gh rh (2003)
02/22/2007US20070042947 Agents for preventing and/or treating uppper digestive tract disorders
02/22/2007US20070042946 Peptide inhibitors of thrombin as potent anticoagulants
02/22/2007US20070042945 Nouvelles compositions et methods de traitement du psoriasis
02/22/2007US20070042944 purification of fibrinogen; loading a solution with fibrinogen and other proteins onto an immobilized metal ion affinity chromatography matrix under conditions such that the fibrinogen and the protein both bind to the matrix, and selectively eluting the fibrinogen; provide a lyophilized product
02/22/2007US20070042941 Galectin 9-inducing factors
02/22/2007US20070042492 Amino acid sequences for transferring substances of interest from outside medium to inside of cells, specifically cell nuclei; useful for enhancing delivery of drugs into cytoplasm and/or the cell nucleus from the host organism being treated
02/22/2007US20070042485 Modified TRAP protein for producing nano-scale electrical devices, and a method for producing such a protein
02/22/2007US20070042474 Corynebacterium glutamicum genes encoding novel proteins
02/22/2007US20070042472 Mammalian transforming growth factor beta-9
02/22/2007US20070042471 Homogeneous preparations of il-28 and il-29
02/22/2007US20070042470 Homogeneous preparations of il-28 and il-29
02/22/2007US20070042469 Homogeneous preparations of IL-29 produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins which has antihepatitis activity
02/22/2007US20070042468 Interferon-like protein zcyto21
02/22/2007US20070042467 NIMA interacting proteins
02/22/2007US20070042466 Il-1 related polypeptides
02/22/2007US20070042465 Mammalian transforming growth factor beta-9
02/22/2007US20070042464 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter
02/22/2007US20070042463 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof
02/22/2007US20070042461 Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof
02/22/2007US20070042460 Oxidation of peptides
02/22/2007US20070042458 Erythropoietin: remodeling and glycoconjugation of erythropoietin
02/22/2007US20070042446 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases
02/22/2007US20070042445 Method for demonstration of a molecular event in a cell by means of fluorescent marker proteins
02/22/2007US20070042438 Scd4ol and placental growth factor (plgf) used as a biochemical marker combination in cardiovascular diseases
02/22/2007US20070042434 Method for identifying tff2 regulating agents and agents identified using said method
02/22/2007US20070042433 Neuregulin protein regulation of synaptic proteins
02/22/2007US20070042431 Methods for reducing complexity of a sample using small epitope antibodies
02/22/2007US20070042425 Diagnostic method for brain damage-related disorders
02/22/2007US20070042420 Liver tumor marker sequences
02/22/2007US20070042417 Use of a nucleic acid probe to detect Zven, a human protein that may inhibit Wnt, and is an agent that stimulates gastrointestinal contractility, gastric emptying, intestinal transit, and treating gastroparesis
02/22/2007US20070042416 Dendritic Enriched Secreted Lymphocyte Activation Molecule
02/22/2007US20070042415 Anti-fused antibodies
02/22/2007US20070042413 Platelet-derived growth factor D, DNA coding therefor, and uses thereof
02/22/2007US20070042410 Screening method for genes of brewing yeast
02/22/2007US20070042403 Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases
02/22/2007US20070042395 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity
02/22/2007US20070042391 useful as molecular targets for diagnostics, prophylaxis and treatment of pathological conditions; for use in generating agents for prevention and treatment of infection
02/22/2007US20070042385 Novel compositions and methods in cancer
02/22/2007US20070042383 for detecting Mycobacterium paratuberculosis in a sample using nucleic acid molecules, polypeptides, and antibodies; for immunization and prevention of mycobacterial animal infections
02/22/2007US20070042382 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
02/22/2007US20070042378 Regulation of prokaryotic gene expression with zinc finger proteins
02/22/2007US20070042376 In gastric cancer and related cancers, a higher expression of CA IX indicates poorer prognosis for afflicted patients, particularly when expressed at the invasion front of the cancer
02/22/2007US20070042375 Isolated berovin photoprotein and use thereof
02/22/2007US20070042374 drug screening; obesity, diabetes mellitus, impaired glucose tolerance, arteriosclerosis, hypertension or hyperlipemia
02/22/2007US20070042363 Novel polypeptide and nucleic acid encoding the same
02/22/2007US20070042361 Human secreted proteins
02/22/2007US20070042359 E-protein specific immunoglobulin for use in treatment and prevention of viral infection
02/22/2007US20070042356 Variants of hepatitis B virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof
02/22/2007US20070042353 HCV polymerase suitable for crystal structure analysis and method for using the enzyme
02/22/2007US20070042345 Polypeptide having intracellular calcium ion indicator function
02/22/2007US20070042344 Differentiation regulating agent containing gene which regulating differentiation from stem cells into natural killer cells as effective ingredient
02/22/2007US20070042339 Preservation of biomaterials with transported preservation agents
02/22/2007US20070042047 Vaccines
02/22/2007US20070042002 Influenza recombinant subunit vaccine
02/22/2007US20070042001 Influenza recombinant subunit vaccine
02/22/2007US20070042000 Porcine reproductive and respiratory syndrome vaccine based on isolate ja-142
02/22/2007US20070041998 Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses
02/22/2007US20070041997 Bacterial virulence factors and uses thereof
02/22/2007US20070041991 amino acid sequence proteins or immunogenic fragments, encoded sequence from isolated nucleic acid; for treating infection caused from Babesiidae; diagnostic test for the detection of nucleic acids, antibodies or antigens of the organism; safe, stable, easily scaleable production; veterinary medicine
02/22/2007US20070041990 Circovirus sequences associated with piglet weight loss disease (PWD)
02/22/2007US20070041989 Circovirus sequences associated with piglet weight loss disease (PWD)
02/22/2007US20070041988 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines
02/22/2007US20070041987 Fragments or polymers of albumin with tunable vascular residence time for use in therapeutic delivery and vaccine development
02/22/2007US20070041985 Modulation of the poliovirus receptor function
02/22/2007US20070041976 Treating septic arthritis; Interleukin-4 (IL-4), previously known as B cell stimulating factor
02/22/2007US20070041975 Homogeneous preparations of il-28 and il-29
02/22/2007US20070041974 Cytokine zalpha11 ligand antibodies
02/22/2007US20070041970 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
02/22/2007US20070041969 Apo-2DcR
02/22/2007US20070041968 Methods of inducing an immune response
02/22/2007US20070041964 WISP polypeptides and nucleic acids encoding same
02/22/2007US20070041963 Human secreted proteins
02/22/2007US20070041958 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
02/22/2007US20070041951 Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof
02/22/2007US20070041945 Novel method for down-regulation of amyloid
02/22/2007US20070041941 Nucleic acid sequences encoding and compositions comrpising ige signal peptide and/or il-15 and methods for using the same
02/22/2007US20070041940 Methods of treating cancer using il-21
02/22/2007US20070041939 Modified cytokines for use in cancer therapy
02/22/2007US20070041938 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
02/22/2007US20070041937 G-csf derivative for inducing immunological tolerance
02/22/2007US20070041936 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing
02/22/2007US20070041902 Somatostatin analogs with inhibitory activity to growth hormone release
02/22/2007CA2656705A1 Influenza recombinant subunit vaccine
02/22/2007CA2619969A1 Glycopegylated factor vii and factor viia
02/22/2007CA2619876A1 Chemically modified short interfering nucleic acid molecules that mediate rna interference
02/22/2007CA2619716A1 Antigenic peptides and their use
02/22/2007CA2619411A1 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress
02/22/2007CA2619048A1 Vegf-activated fas ligands
02/22/2007CA2619017A1 Gdnf derived peptides
02/22/2007CA2618951A1 Mcp1 fusions